logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Gujarat Themis Biosyn Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs
    BSE Code
    ISIN Demat
    Book Value()
    506879
    INE942C01045
    27.7209005
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    GUJTHEMIS
    49.64
    2935.16
    EPS(TTM)
    Face Value()
    Div & Yield %:
    8.14
    1
    0.37
     
Mangalam Drugs & Organics Ltd
Mangalam Drugs and Organics standalone net profit rises 16.28% in the December 2023 quarter
Feb 14,2024
Net profit of Mangalam Drugs and Organics rose 16.28% to Rs 0.50 crore in the quarter ended December 2023 as against Rs 0.43 crore during the previous quarter ended December 2022. Sales rose 54.22% to Rs 97.05 crore in the quarter ended December 2023 as against Rs 62.93 crore during the previous quarter ended December 2022.

ParticularsQuarter Ended
 Dec. 2023Dec. 2022% Var.
Sales97.0562.93 54
OPM %7.1810.30 -
PBDT3.663.39 8
PBT0.040.51 -92
NP0.500.43 16